Drug safety and pharmacovigilance

Drug safety and pharmacovigilance

The Importance of Reporting Adverse Event(s)

In this comprehensive blog, we delve into why reporting adverse events is crucial for public safety and discuss the concerning issue of the rapid and widespread lack of adverse event reports.

Bala

Read

Drug safety and pharmacovigilance

Drug safety and pharmacovigilance: The difference

In this article we explore in to the difference between the terms drug safety and pharmacovigilance. While many of us thinking both are interchangeable, they actually have a distinct meaning. So you land on the right place to clarify and gain knowledge about it.

Bala

Read

Drug safety and pharmacovigilance

Decoding Risk: Why RCA Matters in Pharmacovigilance

In this blog, you’ll explore into the importance and procedures of conducting Root Cause Analysis (RCA) in pharmacovigilance, accompanied by relevant references for deeper understanding.

Bala

Read

Drug safety and pharmacovigilance

Examining Drug Types in PV: Suspected and Concomitant

Welcome to our informative pharmacovigilance blog, where we shed light on the distinction between suspected drugs and concomitant drugs. Gain a deeper understanding of the roles and implications of suspected drugs in post-marketing surveillance and adverse event reporting.

Bala

Read

Drug safety and pharmacovigilance

Evaluation of Benefit-Risk Balance in Pharmacovigilance

In this detailed blog, we delve into the specific aspects of the benefit-risk evaluation process, accompanied by a flow diagram illustrating the sequential steps for proper implementation.

Bala

Read

Drug safety and pharmacovigilance

Pharmacovigilance – The Basics

In this comprehensive blog, where we provide a comprehensive overview of pharmacovigilance. Whether you’re new to the field or seeking a refresher, our blog is here to guide you through the basics of pharmacovigilance.

Bala

Read

Drug safety and pharmacovigilance

Understanding Action Items in pharmacovigilance

From this insightful blog, where you can learn all about action items and provide guidance on how to handle them promptly in various circumstances. By the end of this blog, you’ll have the knowledge to confidently address action items and drive progress.

Bala

Read

Drug safety and pharmacovigilance

Understanding Civil Money Penalties

In this pharmacovigilance blog, we will delve into the details of civil penalties, addressing any uncertainties regarding the amount of penalties for late submissions or the provision of misleading data. Take a moment to read and gain clarity through this blog. Happy reading!

Bala

Read